Mark Li in Wheaton, Maryland

Medical School: Sorry, his university is not listed
Graduation Year: 1977
The Primary Medical Specialty for Mark Li is listed as: Internal Medicine
Approximate Years of Experience: 47
PAC (PECOS ID)#: 6406930882
NPI #: 1356338032
NPI Created On: 09/29/2005
NPI Last Updated Listed as: 04/15/2008
Primary Taxonomy Code: 207R00000X
License Number:
D0027865
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Humana
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,Chinese, Chinese, English, Mandarin.

Services and Procedures include:

1. Insertion of needle into vein, patient 3 years or older
2. Stool analysis for blood to screen for colon tumors
3. Vaccine for influenza for injection into muscle
4. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
5. Routine ekg using at least 12 leads including interpretation and report
6. Ultrasound study of arteries of both arms and legs
7. Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours
8. Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours
9. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
10. New patient office or other outpatient visit, typically 60 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
14. Administration of influenza virus vaccine
15. Administration of pneumococcal vaccine
16. Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
17. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
18. Annual depression screening, 15 minutes
19. Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes
20. Injection, denosumab, 1 mg